A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio.
Mulholland PJ., Brown NF., McBain C., Brazil L., Peoples S., Jefferies S., Harris F., Plaha P., Vinayan A., Brooks C., Hussain S., Dutton SJ., Ng S., Levy S., Coutts T.